Your browser doesn't support javascript.
loading
Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.
Taylor-Rowan, Martin; Kraia, Olga; Kolliopoulou, Christina; Noel-Storr, Anna H; Alharthi, Ahmed A; Cross, Amanda J; Stewart, Carrie; Myint, Phyo K; McCleery, Jenny; Quinn, Terry J.
Afiliação
  • Taylor-Rowan M; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Kraia O; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Kolliopoulou C; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Noel-Storr AH; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Alharthi AA; Department of Clinical Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia.
  • Cross AJ; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia.
  • Stewart C; ACER, IAHS, University of Aberdeen, Aberdeen, UK.
  • Myint PK; Division of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
  • McCleery J; Oxford Health NHS Foundation Trust, Banbury, UK.
  • Quinn TJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Cochrane Database Syst Rev ; 8: CD015196, 2022 08 22.
Article em En | MEDLINE | ID: mdl-35994403
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência / Disfunção Cognitiva Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência / Disfunção Cognitiva Idioma: En Ano de publicação: 2022 Tipo de documento: Article